A rapid, accurate, and easy-to-use diagnostic assay for STIs
一种快速、准确且易于使用的性传播感染诊断方法
基本信息
- 批准号:9347683
- 负责人:
- 金额:$ 69.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-02-07 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:3D PrintAddressAdvanced DevelopmentAffectBedside TestingsBiological AssayBiological SciencesCenters for Disease Control and Prevention (U.S.)ChlamydiaChlamydia trachomatisClinicCollaborationsComb animal structureCommunitiesConsultationsCoupledDNADetectionDevelopmentDevicesDiagnosisDiagnosticDiseaseEctopic PregnancyEnsureEpidemicFluorescenceFutureGonorrheaHealthHealth Care CostsHealth care facilityHealthcareHealthcare SystemsHumanIndividualInfectionInfertilityJailLaboratoriesMagnetismMedicalMethodsMolecularMolecular Diagnostic TestingMovementNeisseria gonorrhoeaeNucleic AcidsPatientsPelvic Inflammatory DiseasePerformancePhasePlayPoint-of-Care SystemsPolymerase Chain ReactionPreparationPrevalenceProcessProtocols documentationPublic HealthReportingRestSamplingSensitivity and SpecificitySepsisSexually Transmitted DiseasesSwabSystemTechnologyTestingTimeTubeUniversitiesUrineVaginaValidationVisitWorkamplification detectionartistbaseclinical diagnosticscommercializationcostcost effectivedesigndetention centerdiagnostic assayimprovedinnovationmolecular diagnosticsnoveloutreachparticlepathogenpoint of careprofessorprototyperisk minimizationscreeningtoolverification and validation
项目摘要
PROJECT SUMMARY
The aim of this Phase II proposal is to develop a rapid, easy-to-use, and inexpensive multi-sample diagnostic
system to identify sexually transmitted infection (STI) pathogens, such as Chlamydia trachomatis (CT) and
Neisseria gonorrhoeae (NG) in non-traditional healthcare settings. The features of our system will likely qualify
it to be a CLIA-waived CT/NG test. The sensitivity and specificity to be achieved using this prototype type
assay will be comparable with those of current laboratory-based molecular tests. This would present a major
advancement in clinical diagnostics for STIs. According to the CDC, chlamydia and gonorrhea, caused by C.
trachomatis and N. gonorrhoeae, are the two most frequently reported STIs in the US and likely the rest of the
world. These STIs are often under-diagnosed, leading to delayed treatment, continued spread and higher
public healthcare costs (~$16 billion annually). As a result of their prevalence and long term health
consequences, there is a need for rapid and sensitive methods of detecting STIs in order for patients to get
results and treatment immediately. It is important that patients receive results and initial consultation or
treatment during the first patient visit, as they rarely return for a second visit. Point-of-care (POC) tests are an
important strategy to address the STI epidemic, and because many affected by STIs (young and/or poor) often
have limited access to traditional healthcare, POC tests that can be performed in non-traditional settings (e.g.,
university clinics, community public health care clinics, jails, and detention centers) could greatly reduce STIs.
The system we propose to further develop will combine AI Biosciences, Inc.’s novel assay cartridge, low-cost
automatic platform inspired by 3D printer technology, and a rapid real-time thermal cycler to form a multi-
sample system for use in non-traditional healthcare settings. A low-cost self-contained nucleic acid extraction
and purification cartridge will be developed to perform a 10 min. extraction process for 6 samples. The
extracted NA samples will then be eluted and amplified using shuttle thermal cycler to perform multiplexed
real-time polymerase chain reaction (PCR) for CT and NG targets (15 min for 40 cycles). We plan to optimize
the assay and disposable to meet the needs of non-traditional healthcare settings, improve the system for
ease-of-use, and minimize risk of erroneous result. We will complete prototype system validation and
verification as well as determine analytical sensitivity and specificity of the CT/NG assay. The proposed work
will be carried out in collaboration with a STI expert in the US. Our proposed technologies are highly suitable
for parallel, automated processing. This is a substantial advantage over other integrated systems being
developed as most can only process one sample at a time, requiring the purchase of several modules in order
to meet the throughput demand in most point-of-care or near-patient settings. The successful development
and commercialization of our medium-throughput technology will impact how molecular diagnostic assays are
implemented in non-traditional healthcare settings.
项目总结
此第二阶段提案的目标是开发一种快速、易用、廉价的多样本诊断方法
识别性传播感染(STI)病原体的系统,如沙眼衣原体(CT)和
非传统医疗环境中的淋球菌(NG)。我们的系统的特点很可能符合
这将是CLIA豁免的CT/NG测试。使用这种原型类型要达到的灵敏度和特异度
测试将与目前以实验室为基础的分子测试相媲美。这将是一个重大的
性传播感染的临床诊断学进展。根据疾控中心的说法,衣原体和淋病由C.
沙眼衣原体和淋病奈瑟菌是美国报告最频繁的两种性传播疾病,很可能是
世界。这些性传播感染往往被低估,导致延迟治疗、继续传播和更高的
公共医疗成本(每年约160亿美元)。由于它们的流行和长期健康
结果,需要快速和灵敏的检测性传播感染的方法,以便患者获得
结果并立即进行治疗。重要的是,患者得到结果和初步咨询或
在第一次就诊期间接受治疗,因为他们很少再回来第二次就诊。护理点(POC)测试是一种
应对性传播感染流行的重要战略,因为许多人(年轻人和/或穷人)经常受到性传播感染的影响
对可在非传统设置中执行的传统医疗保健、PoC测试的访问受限(例如,
大学诊所、社区公共卫生保健诊所、监狱和拘留中心)可以大大减少性传播感染。
我们建议进一步开发的系统将结合AI Biosciences,Inc.的S新型试剂盒,低成本
自动平台灵感来自3D打印机技术,以及快速实时热循环器,形成多个
用于非传统医疗保健环境的示例系统。一种低成本的自给核酸提取方法
并将研制的提纯小柱进行10分钟。6个样品的提取工艺。这个
提取的NA样品将被洗脱,并使用航天飞机热循环仪进行放大以进行多路复用
CT和NG靶点的实时聚合酶链式反应(PCR)(40个周期,15min)。我们计划优化
该化验和一次性服务满足了非传统医疗机构的需求,完善了
易于使用,并将错误结果的风险降至最低。我们将完成原型系统的验证和
验证以及确定CT/NG分析的灵敏度和特异性。拟议中的工作
将与美国的一名STI专家合作进行。我们建议的技术非常适合
用于并行、自动化处理。与其他集成系统相比,这是一个实质性的优势
开发为MOST一次只能处理一个样品,需要按顺序购买几个模块
以满足大多数护理地点或近距离患者设置中的吞吐量需求。成功的开发
我们中通量技术的商业化将影响分子诊断分析的水平
在非传统医疗保健环境中实施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SEASON S-S WONG其他文献
SEASON S-S WONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SEASON S-S WONG', 18)}}的其他基金
Rapid Point-of-Care Molecular Test for SARS-CoV-2 and Influenza A/B
SARS-CoV-2 和甲型/乙型流感的快速护理点分子检测
- 批准号:
10484040 - 财政年份:2022
- 资助金额:
$ 69.76万 - 项目类别:
An Ultrasensitive and Low-Cost p24 Antigen Test for the Early Detection of HIV
用于早期检测 HIV 的超灵敏且低成本的 p24 抗原测试
- 批准号:
10482574 - 财政年份:2022
- 资助金额:
$ 69.76万 - 项目类别:
Rapid and Low- cost POC Assay for Zika Virus Diagnosis
用于寨卡病毒诊断的快速、低成本 POC 检测
- 批准号:
9254690 - 财政年份:2017
- 资助金额:
$ 69.76万 - 项目类别:
Rapid and Ultrasensitive Direct Detection of RNA for Norovirus Gastroenteritis
快速、超灵敏直接检测诺如病毒胃肠炎 RNA
- 批准号:
8833117 - 财政年份:2015
- 资助金额:
$ 69.76万 - 项目类别:
A Portable, Self-Contained Nucleic Acid Extraction and Storage System for POC Tes
用于 POC Tes 的便携式独立核酸提取和存储系统
- 批准号:
8712053 - 财政年份:2014
- 资助金额:
$ 69.76万 - 项目类别:
A rapid, accurate, and easy-to-use diagnostic assay for STIs
一种快速、准确且易于使用的性传播感染诊断方法
- 批准号:
8713686 - 财政年份:2014
- 资助金额:
$ 69.76万 - 项目类别:
A Sensitive and Serotype-Specific Dengue Diagnostic Test for Low-Resource Setting
适用于资源匮乏环境的敏感且血清型特异性的登革热诊断测试
- 批准号:
8713439 - 财政年份:2014
- 资助金额:
$ 69.76万 - 项目类别:
Ultrasensitive, Label-free Silicon Nanowire Biosensing Arrays
超灵敏、无标记硅纳米线生物传感阵列
- 批准号:
7670539 - 财政年份:2009
- 资助金额:
$ 69.76万 - 项目类别:
Sample Preparation and Real-Time PCR System for Non-Traditional Settings
适用于非传统设置的样品制备和实时 PCR 系统
- 批准号:
7608852 - 财政年份:2009
- 资助金额:
$ 69.76万 - 项目类别:
Rapid and Enclosed System for the Identification of Multi-Drug Resistant TB
用于识别多重耐药结核病的快速封闭系统
- 批准号:
7394908 - 财政年份:2008
- 资助金额:
$ 69.76万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Research Grant














{{item.name}}会员




